| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC46A2 SLC9A9 ABCA2 ABCA3 ABCA4 ATP2C1 TMEM241 SLC18A2 SLC7A11 TAP2 SLC38A3 SLC16A12 | 2.61e-09 | 477 | 52 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | transporter activity | SLC46A2 SLC9A9 ABCA2 ABCA3 ABCA4 ATP2C1 TMEM241 SLC18A2 SV2A SLC22A23 HTR3C SLC29A2 SLC7A11 TAP2 PLSCR1 SLC38A3 SLC16A12 | 1.34e-08 | 1289 | 52 | 17 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC46A2 SLC9A9 ABCA2 ABCA3 ABCA4 ATP2C1 TMEM241 SLC18A2 SV2A SLC22A23 HTR3C SLC29A2 SLC7A11 TAP2 SLC38A3 SLC16A12 | 2.74e-08 | 1180 | 52 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 7.94e-06 | 49 | 52 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 9.33e-06 | 51 | 52 | 4 | GO:0140303 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 9.36e-06 | 109 | 52 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.11e-05 | 296 | 52 | 7 | GO:0015291 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR51G2 TAS2R4 OR10H5 OR10H2 OR10H1 OR5I1 OR5AS1 ADGRB2 GPRC5A PTGER2 PTGIR | 1.37e-05 | 884 | 52 | 11 | GO:0004930 |
| GeneOntologyMolecularFunction | antiporter activity | 2.93e-05 | 138 | 52 | 5 | GO:0015297 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 5.21e-05 | 28 | 52 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 9.85e-05 | 178 | 52 | 5 | GO:0015399 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.39e-04 | 441 | 52 | 7 | GO:0016887 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR51G2 TAS2R4 OR10H5 OR10H2 OR10H1 OR5I1 OR5AS1 ADGRB2 HTR3C GPRC5A PTGER2 PTGIR | 1.45e-04 | 1353 | 52 | 12 | GO:0004888 |
| GeneOntologyMolecularFunction | prostaglandin receptor activity | 3.60e-04 | 11 | 52 | 2 | GO:0004955 | |
| GeneOntologyMolecularFunction | prostanoid receptor activity | 4.32e-04 | 12 | 52 | 2 | GO:0004954 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 4.89e-04 | 59 | 52 | 3 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 4.89e-04 | 59 | 52 | 3 | GO:0015932 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 5.93e-04 | 14 | 52 | 2 | GO:0140333 | |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 7.80e-04 | 16 | 52 | 2 | GO:0015385 | |
| GeneOntologyMolecularFunction | icosanoid receptor activity | 7.80e-04 | 16 | 52 | 2 | GO:0004953 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | 8.23e-04 | 775 | 52 | 8 | GO:0017111 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 8.59e-04 | 431 | 52 | 6 | GO:0004984 | |
| GeneOntologyMolecularFunction | flippase activity | 8.82e-04 | 17 | 52 | 2 | GO:0140327 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 9.48e-04 | 74 | 52 | 3 | GO:0005548 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 9.72e-04 | 293 | 52 | 5 | GO:0008514 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 1.01e-03 | 614 | 52 | 7 | GO:0140657 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | 1.37e-03 | 839 | 52 | 8 | GO:0016462 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | 1.38e-03 | 840 | 52 | 8 | GO:0016817 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 1.38e-03 | 840 | 52 | 8 | GO:0016818 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.69e-03 | 196 | 52 | 4 | GO:0005319 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 2.24e-03 | 27 | 52 | 2 | GO:0051139 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 3.34e-03 | 33 | 52 | 2 | GO:0072349 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 3.54e-03 | 34 | 52 | 2 | GO:0042910 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 5.61e-03 | 43 | 52 | 2 | GO:0140828 | |
| GeneOntologyMolecularFunction | symporter activity | 7.02e-03 | 150 | 52 | 3 | GO:0015293 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 7.77e-03 | 301 | 52 | 4 | GO:0022853 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.00e-02 | 171 | 52 | 3 | GO:0015081 | |
| GeneOntologyBiologicalProcess | lipid translocation | 1.70e-05 | 60 | 53 | 4 | GO:0034204 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 2.34e-05 | 65 | 53 | 4 | GO:0097035 | |
| GeneOntologyBiologicalProcess | import into cell | SLC46A2 SLC9A9 RIN3 ABCA2 SLC18A2 WNT5A SLC29A2 SLC7A11 PLSCR1 SLC38A3 TBC1D24 | 7.35e-05 | 1074 | 53 | 11 | GO:0098657 |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 7.38e-05 | 87 | 53 | 4 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 7.72e-05 | 88 | 53 | 4 | GO:0010232 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | SLC46A2 SLC9A9 ABCA2 ABCA3 ABCA4 FIG4 SLC18A2 SV2A WNT5A GPRC5A TAP2 TBC1D24 | 8.25e-05 | 1307 | 53 | 12 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | SLC46A2 SLC9A9 ABCA2 ABCA3 ABCA4 FIG4 SLC18A2 SV2A WNT5A GPRC5A TAP2 TBC1D24 | 9.41e-05 | 1325 | 53 | 12 | GO:0012506 |
| MousePheno | increased circulating cysteine level | 3.86e-05 | 4 | 36 | 2 | MP:0030625 | |
| MousePheno | atrioventricular septal defect | 6.17e-05 | 84 | 36 | 4 | MP:0010412 | |
| MousePheno | increased cysteine level | 6.42e-05 | 5 | 36 | 2 | MP:0030622 | |
| MousePheno | abnormal atrioventricular septum morphology | 7.08e-05 | 87 | 36 | 4 | MP:0010592 | |
| Domain | MFS_dom | 1.32e-06 | 134 | 49 | 6 | IPR020846 | |
| Domain | ABC_A | 3.67e-06 | 12 | 49 | 3 | IPR026082 | |
| Domain | ABC_transporter_CS | 4.35e-06 | 42 | 49 | 4 | IPR017871 | |
| Domain | ABC_TRANSPORTER_2 | 7.47e-06 | 48 | 49 | 4 | PS50893 | |
| Domain | ABC_tran | 7.47e-06 | 48 | 49 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 8.12e-06 | 49 | 49 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 8.81e-06 | 50 | 49 | 4 | IPR003439 | |
| Domain | MFS | 9.17e-06 | 108 | 49 | 5 | PS50850 | |
| Domain | AAA+_ATPase | 3.69e-05 | 144 | 49 | 5 | IPR003593 | |
| Domain | AAA | 3.69e-05 | 144 | 49 | 5 | SM00382 | |
| Domain | MFS | 4.91e-05 | 77 | 49 | 4 | IPR011701 | |
| Domain | MFS_1 | 4.91e-05 | 77 | 49 | 4 | PF07690 | |
| Domain | Thbox_rcpt | 6.71e-05 | 5 | 49 | 2 | IPR001105 | |
| Domain | Prostanoid_rcpt | 1.87e-04 | 8 | 49 | 2 | IPR008365 | |
| Domain | GPCR_Rhodpsn_7TM | 3.23e-04 | 670 | 49 | 8 | IPR017452 | |
| Domain | 7tm_1 | 3.46e-04 | 677 | 49 | 8 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 3.74e-04 | 685 | 49 | 8 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 3.97e-04 | 691 | 49 | 8 | PS50262 | |
| Domain | GPCR_Rhodpsn | 4.01e-04 | 692 | 49 | 8 | IPR000276 | |
| Domain | Olfact_rcpt | 5.44e-04 | 393 | 49 | 6 | IPR000725 | |
| Domain | - | 6.59e-04 | 746 | 49 | 8 | 3.40.50.300 | |
| Domain | P-loop_NTPase | 1.51e-03 | 848 | 49 | 8 | IPR027417 | |
| Domain | Sugar_transporter_CS | 3.18e-03 | 32 | 49 | 2 | IPR005829 | |
| Domain | Sugar_tr | 4.01e-03 | 36 | 49 | 2 | PF00083 | |
| Domain | MFS_sugar_transport-like | 4.01e-03 | 36 | 49 | 2 | IPR005828 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC9A9 ABCA2 ABCA3 ABCA4 ATP2C1 PSME4 SLC18A2 PARL SLC29A2 SLC7A11 SLC38A3 | 2.58e-06 | 681 | 41 | 11 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC9A9 ABCA2 ABCA3 ABCA4 ATP2C1 PSME4 SLC18A2 PARL SLC29A2 SLC7A11 SLC38A3 | 5.46e-06 | 736 | 41 | 11 | M27287 |
| Pathway | KEGG_ABC_TRANSPORTERS | 7.68e-06 | 44 | 41 | 4 | M11911 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 1.90e-04 | 99 | 41 | 4 | MM14986 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 2.13e-04 | 190 | 41 | 5 | MM15687 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 2.21e-04 | 103 | 41 | 4 | M758 | |
| Pathway | REACTOME_PROSTANOID_LIGAND_RECEPTORS | 2.93e-04 | 9 | 41 | 2 | MM15014 | |
| Pathway | REACTOME_PROSTANOID_LIGAND_RECEPTORS | 2.93e-04 | 9 | 41 | 2 | M804 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 4.19e-04 | 636 | 41 | 8 | M41834 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 6.00e-04 | 238 | 41 | 5 | MM15076 | |
| Pathway | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | 7.35e-04 | 14 | 41 | 2 | MM15012 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 7.36e-04 | 249 | 41 | 5 | M5988 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 8.43e-04 | 389 | 41 | 6 | M14091 | |
| Pathway | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | 8.46e-04 | 15 | 41 | 2 | M10620 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 8.94e-04 | 260 | 41 | 5 | M39397 | |
| Pathway | WP_GPCRS_NONODORANT | 9.91e-04 | 266 | 41 | 5 | MM15843 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 1.09e-03 | 17 | 41 | 2 | MM14552 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 1.09e-03 | 70 | 41 | 3 | MM14984 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 1.21e-03 | 417 | 41 | 6 | M4072 | |
| Pathway | WP_GPCRS_SMALL_LIGAND | 1.23e-03 | 18 | 41 | 2 | MM15858 | |
| Pathway | REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | 1.23e-03 | 18 | 41 | 2 | M524 | |
| Pathway | WP_SMALL_LIGAND_GPCRS | 1.37e-03 | 19 | 41 | 2 | M39728 | |
| Pathway | BIOCARTA_EICOSANOID_PATHWAY | 1.52e-03 | 20 | 41 | 2 | MM1529 | |
| Pathway | BIOCARTA_EICOSANOID_PATHWAY | 1.84e-03 | 22 | 41 | 2 | M22003 | |
| Pubmed | Prostaglandin receptors EP2 and IP are detectable in atherosclerotic arteries and plaques. | 2.28e-06 | 2 | 53 | 2 | 20357748 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 31317476 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 28813580 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 24603532 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 24145140 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 11238561 | ||
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 1.69e-05 | 100 | 53 | 4 | 25807483 | |
| Pubmed | 2.05e-05 | 105 | 53 | 4 | 30280653 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 16446378 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 15372104 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 11301049 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 30894622 | ||
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 18005048 | ||
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 23850867 | ||
| Pubmed | Isolation and characterization of spheroid cells from human malignant melanoma cell line WM-266-4. | 3.40e-05 | 6 | 53 | 2 | 19940551 | |
| Pubmed | Chromosomal localization of the human prostanoid receptor gene family. | 3.40e-05 | 6 | 53 | 2 | 7759114 | |
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 21835766 | ||
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 15983244 | ||
| Pubmed | Pkd1 and Wnt5a genetically interact to control lymphatic vascular morphogenesis in mice. | 4.76e-05 | 7 | 53 | 2 | 34174014 | |
| Pubmed | 4.76e-05 | 7 | 53 | 2 | 26018088 | ||
| Pubmed | Hematopoietic stem cell regeneration through paracrine regulation of the Wnt5a/Prox1 signaling axis. | 4.76e-05 | 7 | 53 | 2 | 35703178 | |
| Pubmed | Notch-Wnt-Bmp crosstalk regulates radial patterning in the mouse cochlea in a spatiotemporal manner. | 6.34e-05 | 8 | 53 | 2 | 27633988 | |
| Pubmed | Prostanoid receptors: structures, properties, and functions. | 6.34e-05 | 8 | 53 | 2 | 10508233 | |
| Pubmed | Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis. | 6.34e-05 | 8 | 53 | 2 | 20566843 | |
| Pubmed | Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia. | 6.34e-05 | 8 | 53 | 2 | 15834430 | |
| Pubmed | 6.34e-05 | 8 | 53 | 2 | 24293640 | ||
| Pubmed | 6.34e-05 | 8 | 53 | 2 | 11927615 | ||
| Pubmed | 6.34e-05 | 8 | 53 | 2 | 19966781 | ||
| Pubmed | Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma. | 6.34e-05 | 8 | 53 | 2 | 17496729 | |
| Pubmed | 7.00e-05 | 52 | 53 | 3 | 26590417 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 7.74e-05 | 1203 | 53 | 9 | 29180619 | |
| Pubmed | Mechanosensitive mTORC1 signaling maintains lymphatic valves. | 8.15e-05 | 9 | 53 | 2 | 37036444 | |
| Pubmed | 8.15e-05 | 9 | 53 | 2 | 21460251 | ||
| Pubmed | Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis. | 8.15e-05 | 9 | 53 | 2 | 11782353 | |
| Pubmed | Mechanistic definition of the cardiovascular mPGES-1/COX-2/ADMA axis. | 8.15e-05 | 9 | 53 | 2 | 31688905 | |
| Pubmed | 1.24e-04 | 11 | 53 | 2 | 30100344 | ||
| Pubmed | 1.49e-04 | 12 | 53 | 2 | 26859490 | ||
| Pubmed | 1.70e-04 | 541 | 53 | 6 | 14983052 | ||
| Pubmed | Alternative splice variants encoding unstable protein domains exist in the human brain. | 1.76e-04 | 13 | 53 | 2 | 15491607 | |
| Pubmed | 2.18e-04 | 193 | 53 | 4 | 19343046 | ||
| Pubmed | 2.36e-04 | 15 | 53 | 2 | 24035762 | ||
| Pubmed | LDB1 Is Required for the Early Development of the Dorsal Telencephalon and the Thalamus. | 2.70e-04 | 16 | 53 | 2 | 30873428 | |
| Pubmed | Genetic predictors of fibrin D-dimer levels in healthy adults. | 2.70e-04 | 16 | 53 | 2 | 21502573 | |
| Pubmed | 2.70e-04 | 16 | 53 | 2 | 19890917 | ||
| Pubmed | 3.43e-04 | 18 | 53 | 2 | 24874739 | ||
| Pubmed | 3.83e-04 | 19 | 53 | 2 | 21052031 | ||
| Pubmed | 4.25e-04 | 20 | 53 | 2 | 17965409 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 4.40e-04 | 1201 | 53 | 8 | 35696571 | |
| Pubmed | 4.70e-04 | 21 | 53 | 2 | 23137377 | ||
| Pubmed | 5.01e-04 | 101 | 53 | 3 | 9872452 | ||
| Pubmed | 5.16e-04 | 22 | 53 | 2 | 15342729 | ||
| Pubmed | 5.65e-04 | 23 | 53 | 2 | 17644613 | ||
| Pubmed | 5.65e-04 | 23 | 53 | 2 | 8799160 | ||
| Pubmed | Lymphatic function is required prenatally for lung inflation at birth. | 6.16e-04 | 24 | 53 | 2 | 24733830 | |
| Pubmed | 6.16e-04 | 24 | 53 | 2 | 15858069 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 6.54e-04 | 697 | 53 | 6 | 28298427 | |
| Pubmed | 6.68e-04 | 25 | 53 | 2 | 17468181 | ||
| Pubmed | Replication of a genome-wide case-control study of esophageal squamous cell carcinoma. | 7.80e-04 | 27 | 53 | 2 | 18649358 | |
| Pubmed | 7.80e-04 | 27 | 53 | 2 | 23624557 | ||
| Pubmed | Genetic link between renal birth defects and congenital heart disease. | 8.40e-04 | 28 | 53 | 2 | 27002738 | |
| Pubmed | Emx1 and Emx2 cooperate in initial phase of archipallium development. | 8.40e-04 | 28 | 53 | 2 | 15147765 | |
| Pubmed | 8.40e-04 | 28 | 53 | 2 | 15917450 | ||
| Pubmed | 9.64e-04 | 30 | 53 | 2 | 35682694 | ||
| Pubmed | 1.03e-03 | 31 | 53 | 2 | 32046118 | ||
| Pubmed | 1.03e-03 | 31 | 53 | 2 | 22889265 | ||
| Pubmed | 1.03e-03 | 31 | 53 | 2 | 15217342 | ||
| Pubmed | Amino acid transport across mammalian intestinal and renal epithelia. | 1.03e-03 | 31 | 53 | 2 | 18195088 | |
| Pubmed | 1.03e-03 | 31 | 53 | 2 | 37838801 | ||
| Pubmed | 1.03e-03 | 31 | 53 | 2 | 37816598 | ||
| Pubmed | Maternal synchronization of gestational length and lung maturation. | 1.03e-03 | 31 | 53 | 2 | 22096492 | |
| Pubmed | Genome-wide association scan for survival on dialysis in African-Americans with type 2 diabetes. | 1.10e-03 | 32 | 53 | 2 | 21546767 | |
| Pubmed | 1.17e-03 | 33 | 53 | 2 | 39002541 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.38e-03 | 1105 | 53 | 7 | 35748872 | |
| Interaction | NDFIP1 interactions | 5.54e-06 | 105 | 49 | 5 | int:NDFIP1 | |
| Interaction | FZD2 interactions | 1.36e-05 | 60 | 49 | 4 | int:FZD2 | |
| Interaction | SNX14 interactions | 1.55e-05 | 62 | 49 | 4 | int:SNX14 | |
| Interaction | TMPRSS12 interactions | 2.31e-05 | 23 | 49 | 3 | int:TMPRSS12 | |
| Interaction | DNAJC18 interactions | 3.30e-05 | 75 | 49 | 4 | int:DNAJC18 | |
| Interaction | CLEC2D interactions | 1.14e-04 | 197 | 49 | 5 | int:CLEC2D | |
| Interaction | HTR3A interactions | 1.37e-04 | 108 | 49 | 4 | int:HTR3A | |
| Cytoband | 3q27.1 | 4.34e-04 | 27 | 52 | 2 | 3q27.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q24 | 1.32e-03 | 47 | 52 | 2 | chr3q24 | |
| Cytoband | 19p13.1 | 1.37e-03 | 48 | 52 | 2 | 19p13.1 | |
| Cytoband | 16p13.3 | 2.70e-03 | 244 | 52 | 3 | 16p13.3 | |
| GeneFamily | Solute carriers | SLC46A2 SLC9A9 SLC18A2 SLC22A23 SLC29A2 SLC7A11 SLC38A3 SLC16A12 | 2.98e-06 | 395 | 42 | 8 | 752 |
| GeneFamily | ATP binding cassette subfamily A | 4.17e-06 | 14 | 42 | 3 | 805 | |
| GeneFamily | Prostaglandin (prostanoid) receptors | 1.88e-04 | 9 | 42 | 2 | 207 | |
| GeneFamily | Olfactory receptors, family 10 | 4.82e-04 | 66 | 42 | 3 | 157 | |
| ToppCell | IPF-Myeloid-DC_Mature|Myeloid / Disease state, Lineage and Cell class | 2.75e-06 | 189 | 52 | 5 | 49e67d298d045f29136919b7d9971b6502b0efaa | |
| ToppCell | COPD-Myeloid-DC_Mature|Myeloid / Disease state, Lineage and Cell class | 2.97e-06 | 192 | 52 | 5 | baebd462f464e7d0e462d07a74bb5d685a9fc3b6 | |
| ToppCell | PBMC-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 1.77e-05 | 133 | 52 | 4 | e53fbd69775a4bff61de82557342f7ac80915c4d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.23e-05 | 141 | 52 | 4 | 3fa3d2a8ebd9c285168ecea6db9cad74d3a3e85a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.23e-05 | 141 | 52 | 4 | cabb5b8c0874813c713508af2ac620ab0d61ab6f | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-05 | 145 | 52 | 4 | 80684ec249fa445c1b35f94608a4a6824d53f2d9 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-E_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.48e-05 | 145 | 52 | 4 | cb534333fba44b241b14fb0d7b74e843f4e7f9f8 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.07e-05 | 153 | 52 | 4 | cda759ab83a271974651fe4faa21ed4f7ecbb3ae | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.42e-05 | 168 | 52 | 4 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-mature_conventional_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.73e-05 | 171 | 52 | 4 | d934d68efc5739483c735dc702ccd30b07a6aa7e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.84e-05 | 172 | 52 | 4 | a9e65201ad9ab4f64251aba2c0bb3d8f9e0193b6 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.84e-05 | 172 | 52 | 4 | 26006967d0c82f7bd9b36a18e97a1b93e856aa67 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.95e-05 | 173 | 52 | 4 | 09a13407a41ff2cba82fc417b72bf9a24ce6c42e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.95e-05 | 173 | 52 | 4 | bfec038a6783f166240da4861e100643c6ea80a5 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.41e-05 | 177 | 52 | 4 | a0ff337f11bdb11959ac71805ff94be6b4ec1083 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.65e-05 | 179 | 52 | 4 | 40c65e8623547aeb80f9cd2366e29072467ce069 | |
| ToppCell | VE-matDC|VE / Condition, Cell_class and T cell subcluster | 5.90e-05 | 181 | 52 | 4 | 982fd96ef75bc9ab2c2f4970c01b76ba7a164871 | |
| ToppCell | VE-matDC-|VE / Condition, Cell_class and T cell subcluster | 5.90e-05 | 181 | 52 | 4 | 6252184ef098b911df50be4fe1b5565849a5b6b8 | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.16e-05 | 183 | 52 | 4 | b153425ab0df1e5fa9b953e1f6d4e8e3dc6621b0 | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.16e-05 | 183 | 52 | 4 | 19e7be1cfdd111bfb840532a6f7c780345dffccf | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.42e-05 | 185 | 52 | 4 | 5527fa9d2e0b2f3607602e18ba94de4e9bbc6824 | |
| ToppCell | PBMC-Control-cDC_10|Control / Compartment, Disease Groups and Clusters | 6.42e-05 | 185 | 52 | 4 | 4b5a7450fed912f340da16065c1e65d626dbe8d1 | |
| ToppCell | IPF-Myeloid-DC_Mature|World / Disease state, Lineage and Cell class | 6.56e-05 | 186 | 52 | 4 | d0d3953d9b199e0e792990b8551efb993393fe7e | |
| ToppCell | normal_Lung-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 6.56e-05 | 186 | 52 | 4 | 00ad1239b952119b3fd2e6af8f034cba3488f9c1 | |
| ToppCell | IPF-Myeloid-DC_Mature|IPF / Disease state, Lineage and Cell class | 6.69e-05 | 187 | 52 | 4 | 63e0304a0183b69aebb0d1a4640a506a0d6fb6e9 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.69e-05 | 187 | 52 | 4 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.83e-05 | 188 | 52 | 4 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | lymphoid-NK_cell-TNFRSF18+IL7R+_NK_cell|NK_cell / Lineage, cell class and subclass | 7.12e-05 | 190 | 52 | 4 | 16e408436fa663cdf86e38311a7aed4e02c28579 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.41e-05 | 192 | 52 | 4 | 8769b67d1cad1be65da3938f916e5bf88f88f6b8 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.41e-05 | 192 | 52 | 4 | 2c69f3f388b69fb1c1968c923cdbab90658883dd | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.41e-05 | 192 | 52 | 4 | d5a7b546ebfb2e757dd9c64cb1b651f6ed0e0fc7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.41e-05 | 192 | 52 | 4 | 7af2b5240b1fad2177d8022e5f4fc1fe9e8f03b5 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.41e-05 | 192 | 52 | 4 | 6c089bde63dd5f16a07c5929fb49df600f0b21ab | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.41e-05 | 192 | 52 | 4 | 32e4a180037e516c5cc798cd9dada9385e0f43ae | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 7.41e-05 | 192 | 52 | 4 | e44e37e5aeba8628556020d05e1606b28e2faa4f | |
| ToppCell | Control-Myeloid-Migratory_DC|Myeloid / Condition, Lineage and Cell class | 7.87e-05 | 195 | 52 | 4 | 9f1ad04abc6a6c5e093ea24b60732871b1fad5a4 | |
| ToppCell | BAL-Control-cDC_10|Control / Compartment, Disease Groups and Clusters | 8.03e-05 | 196 | 52 | 4 | c32b7b7e6a4781c19c30c6e32d5563f82355deb0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.03e-05 | 196 | 52 | 4 | 12d9028f90c057c6e5cff00301793fa550e86c5a | |
| ToppCell | BAL-Mild-cDC_10|Mild / Compartment, Disease Groups and Clusters | 8.19e-05 | 197 | 52 | 4 | c0550d41dd5619b369b590f3d6a61154dd7b2cab | |
| ToppCell | AT2_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 8.19e-05 | 197 | 52 | 4 | 8b5d4e1c33a57c899c51feb9a6f347232f8910a3 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.51e-05 | 199 | 52 | 4 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.51e-05 | 199 | 52 | 4 | e9c83555d2197b740797a9f33b64f8f7a7ba1ee2 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_epineurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.68e-05 | 200 | 52 | 4 | 24e13b6d9d2d8b29df1f02544ea9c50084d9e75c | |
| Disease | VACTERL association (implicated_via_orthology) | 3.87e-05 | 6 | 48 | 2 | DOID:14679 (implicated_via_orthology) | |
| Disease | Asthma, Aspirin-Induced | 2.00e-04 | 13 | 48 | 2 | C1319853 | |
| Disease | Idiopathic Pulmonary Fibrosis | 5.34e-04 | 21 | 48 | 2 | C1800706 | |
| Disease | D dimer measurement | 1.09e-03 | 30 | 48 | 2 | EFO_0004507 | |
| Disease | intraocular pressure measurement | 1.39e-03 | 509 | 48 | 5 | EFO_0004695 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CTMTAAFLHFFFLSS | 996 | O60241 | |
| STATIMLCFLLSTFF | 741 | P78363 | |
| MLCFLLSTFFSKASL | 746 | P78363 | |
| FLVLSTGMFCSSSAF | 176 | Q9H6U8 | |
| LCFAISTISFSFMVS | 351 | Q99758 | |
| CTFTFSSFLYTVDSM | 176 | Q8WXA8 | |
| ASATMDTARFSTFFD | 551 | O60231 | |
| TFTCFVFFDMFNALS | 811 | P98194 | |
| SFALFMVCVADSFTT | 111 | Q9BUV8 | |
| FLMALTFLMSSFTFC | 186 | Q8NFJ5 | |
| FCTFADTESFILAAM | 106 | Q13606 | |
| FSLLFKSSDFLEMNF | 181 | Q8NAB2 | |
| TMFFSICFSFRAVLE | 461 | Q9Y4B6 | |
| SIAFLACASQMFFSF | 91 | Q8NGA6 | |
| SIAFLACASQMFFSF | 91 | O60403 | |
| ACFLIDFMFFESTGS | 296 | O15162 | |
| CFSFLESSVLLSMAF | 111 | Q8NGK0 | |
| SRACTYFAFAMTFFS | 106 | P43116 | |
| GCALQMFFFASFADA | 96 | Q8N127 | |
| MFFFASFADAECLIL | 101 | Q8N127 | |
| ACMENTDAFLFLFSF | 131 | Q9BU20 | |
| TMSKFTFTDCTRFDA | 1906 | Q8NCM8 | |
| SFCCSLSELFMSSFQ | 196 | P24001 | |
| TTSEAFFGIFAEFMS | 1171 | A4D2P6 | |
| DCLMSFSDFLFAFQI | 131 | Q9H6J7 | |
| YELSSFDDTFCLAMT | 681 | Q92562 | |
| LAARFFDSMCLESFT | 1566 | Q9BZC7 | |
| FMFGCFLSTDEIAFS | 561 | Q56NI9 | |
| SIFDFSSGECVATMF | 686 | O60336 | |
| AFCSFSLSFFALALS | 101 | Q6ZPB5 | |
| FLALLMFAFSTFEES | 11 | Q8IZU8 | |
| SIAFLACASQMFFSF | 91 | Q9Y4A9 | |
| RLSFASFSSMFHAFL | 581 | Q8TB24 | |
| CSPMLLSTFSHFSLF | 206 | Q9H300 | |
| FFSITMASVCFINSF | 126 | Q14542 | |
| SSGFSLSCMVFFLIA | 216 | Q99624 | |
| FTDCLFFGSLMSATD | 201 | Q8IVB4 | |
| AAFLLCGFSMIFSSV | 441 | Q6ZSM3 | |
| TMFSTLRFFEGFCLA | 281 | A1A5C7 | |
| SAFFAKARATFFSAM | 31 | Q92786 | |
| SAIFFMCLFSFGSSL | 191 | Q03519 | |
| MFSCFCFSLQDNSFS | 1 | Q8NE31 | |
| SSVMSCVSCFFLSFG | 631 | Q7L0J3 | |
| QSFLAFESSCMTFGD | 171 | Q9ULP9 | |
| FSFTCLFMVALSLYS | 431 | Q9UPY5 | |
| EFAYTSVLSFDFCSM | 271 | O95625 | |
| LCDAFAFAMTFFGLA | 91 | P43119 | |
| MSSKFFLVALAIFFS | 21 | P41221 | |
| DFSKCMITFQFIATF | 496 | Q14997 | |
| CCASGFLGFFLMFST | 221 | Q24JQ0 | |
| MFVGSCFALSSFLSF | 436 | Q9BY10 | |
| FCIMFVSTIMFAFSS | 166 | Q05940 | |
| AFFFFFTLLMLCVSS | 106 | Q96SA4 | |
| SAFFVLCFMFLDSSS | 81 | Q9NYW5 | |
| AFLALAHSSFFTMFF | 91 | Q6ZT21 |